Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Hologram and Microtext Drug Labels Deter Counterfeits

With patient safety and reputations at risk, pharma companies are turning to ‘smart’ packaging to crack down on counterfeit drugs.

Pharma Serialization / Image: Getty Images
Pharma Serialization / Image: Getty Images

A recent Huffington Post article, focused on smart packaging in the pharmaceutical industry, highlighted steps drug companies are taking to protect both patients and their reputations. The commercialization of expensive and sophisticated biotechnology-based drugs is expected to give the pharmaceutical market above-average growth with regard to smart packaging. The International Trade Administration estimates the global counterfeit drug market to be as high as $200 billion, with an estimated 36,000 rogue Internet pharmacies.

The article notes two specific defenses against counterfeits in the form of smart packaging: holograms and microtext. Holograms have become one of the most prevalent methods as they’re difficult to copy and can be produced in the form of labels, seals, hot-stamped patches, and blister pack foils. Microtext is text that is invisible to the naked eye, but can be seen with the aid of a magnification device. The pharmaceutical packaging industry, led by North America and Europe, was valued at $56.9 billion in 2013, but is expected to reach $83 billion by 2020.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?